Bipolar Disorder News and Research

Latest Bipolar Disorder News and Research

Memphis Mayor supports new program that assists individuals with bipolar disorder

On November 17 at 2:00 pm, Memphis Mayor AC Wharton will announce during a press conference at the University of Tennessee Health Science Center his support for the a new cooperative venture that assists individuals with bipolar disorder.

13 Nov 2009

Memphis Mayor supports National Bipolar Foundation; sees benefit in preventative care program

Memphis Mayor, A.C. Wharton stands up for the outstanding Memphis-based National Bipolar Foundation; a press conference is to be hosted by University of Tennessee Health & Science Center on November 17th at 2pm at the Student Center at 800 Madison in Room 305.

12 Nov 2009

Malfunctioning circadian clock genes may be associated with bipolar disorder in children

Malfunctioning circadian clock genes may be responsible for bipolar disorder in children. Researchers writing in the open access journal BMC Psychiatry found four versions of the regulatory gene RORB that were associated with pediatric bipolar disorder.

11 Nov 2009

Online patient support program for ADHD patients taking Vyvanse Capsules CII medication

Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today announced the re-launch of FOCUS (http://www.vyvanseFOCUS.com), a free, online patient support program for adults taking once-daily Vyvanse® (lisdexamfetamine dimesylate) Capsules CII for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD), and the only online, branded personalized patient support program providing tips and tools for adults diagnosed with ADHD taking a prescription medication.

11 Nov 2009

Bipolar disorder drug market to decline from $6.3 billion to $5 billion

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that widespread generic erosion of branded atypical antipsychotics will cause the bipolar disorder drug market to decline from $6.3 billion in 2008 to approximately $5 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

6 Nov 2009

Second-quarter fiscal 2010 results announced by Repligen

Repligen Corporation today reported results for the second quarter of fiscal year 2010, ended September 30, 2009. Total revenue for the quarter was $5,421,000 compared to total revenue of $5,090,000 for the second quarter of fiscal year 2009 ended September 30, 2008.

5 Nov 2009

International Omega-3 Awareness Day to educate public about proven health benefits of omega-3

Scientific evidence of the health benefits of omega-3's are now so firmly established that omega-3 expert Carol A. Locke, MD, with a team of world-renowned doctors, has spearheaded the first ever International Omega-3 Awareness Day on March 3rd, 2010. Learn more at www.Omega3Day.com.

4 Nov 2009

Shire to present key data on ADHD treatments at national psychiatric meeting

Shire plc, the global specialty biopharmaceutical company, announced today that it will present key scientific data on its Attention-Deficit/Hyperactivity Disorder (ADHD) treatments, INTUNIV- (guanfacine) Extended Release Tablets, Vyvanse- (lisdexamfetamine dimesylate) Capsules CII, and Daytrana- (methylphenidate transdermal system) CII, at a national meeting of psychiatrists to be held October 27 - November 1 in Honolulu.

31 Oct 2009

Shire announces Phase IIIb study results of Daytrana

Shire plc, the global specialty biopharmaceutical company, today announced findings at a major medical meeting from a Phase IIIb study of the tolerability and effectiveness of Daytrana® (methylphenidate transdermal system) in adolescents aged 13 to 17 years diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD).

31 Oct 2009

NARSAD to present Productive Lives Award to Randy Lewis

Randy Lewis, the SVP of supply chain and logistics for Walgreens, the nation’s largest drugstore chain, will receive the first ever Productive Lives Award from NARSAD tonight at its 22nd annual New York Awards Dinner at the Pierre Hotel.

30 Oct 2009

Shire's ADHD treatment data to be presented at the Honolulu psychiatric meeting

Shire plc, the global specialty biopharmaceutical company, announced today that it will present key scientific data on its Attention-Deficit/Hyperactivity Disorder (ADHD) treatments, INTUNIV(TM) (guanfacine) Extended Release Tablets, Vyvanse®( ) (lisdexamfetamine dimesylate) Capsules CII, and Daytrana®( ) (methylphenidate transdermal system) CII, at a national meeting of psychiatrists to be held October 27 - November 1 in Honolulu.

30 Oct 2009

NBPF develops 'Safe 'til Stable' preventative care program for bipolar disorder patients

A major breakthrough in mental health has been developed, a cooperative venture between the National Bipolar Foundation and the MedicAlert Foundation; a preventative care program called "Safe 'til Stable." It provides vital medical information to emergency responders in time of need through our live 24-hour emergency response service.

28 Oct 2009

Pediatric and adolescent patients who receive antipsychotic medications experience weight gain

Many pediatric and adolescent patients who received second-generation antipsychotic medications experienced significant weight gain, along with varied adverse effects on cholesterol and triglyceride levels and other metabolic measures, according to a study in the October 28 issue of JAMA.

28 Oct 2009

ADA Technologies to develop home lithiummonitor for patients with bipolar disorder

ADA Technologies, Inc. (ADA) received a $189,886 grant from the National Institute of Mental Health to develop a home lithiummonitor for use by patients with bipolar disorder.

26 Oct 2009

Shire announces new pharmacokinetic data of ADHD medication

Shire plc, the global specialty biopharmaceutical company, announced new data about the pharmacokinetics of its Attention-Deficit/Hyperactivity Disorder (ADHD) medication, Vyvanse- (lisdexamfetamine dimesylate) Capsules CII, which showed that Vyvanse provided similar concentrations of its active medication in the blood when administered either intranasally or when administered orally.

23 Oct 2009

SAMHSA honors contributors to mental health recovery at the 2009 Voice Awards

Writers and producers from The Soloist, "Grey's Anatomy," "United States of Tara," "90210," and others were honored by the Substance Abuse and Mental Health Services Administration (SAMHSA) for increasing awareness of mental health issues and the power of recovery at the 2009 Voice Awards last night. The event was hosted by Academy Award-winning actor and mental health consumer Richard Dreyfuss at Paramount Studios in Los Angeles.

15 Oct 2009

WCMC-Q program highlights the importance of mental health to overall physical health

Mental health professionals from Weill Cornell Medical College in Qatar and the community highlighted the importance of mental health to overall physical health during a presentation Sunday as part of the medical college's recognition of World Mental Health Day.

12 Oct 2009

Three hundred participants sought for world-first study to determine shared biological basis for psychotic illnesses

For the first time, sufferers of schizophrenia and bipolar disorder are being brought together in a major new study investigating the diseases' common genetic causes and manifestations.

11 Oct 2009

DoD funds Screening for Mental Health's awareness program for military personnel

Screening for Mental Health, Inc. (SMH) today announced that they have received funding from the Department of Defense (DoD) to continue their work with Military Pathways™, a mental health awareness and education program that offers free, anonymous mental health self-assessments to veterans and personnel from all branches of the military as well as their families.

8 Oct 2009

Study shows that GSK-3 gene determines the total number of neurons required for brain

In populating the growing brain, neural stem cells must strike a delicate balance between two key processes - proliferation, in which the cells multiply to provide plenty of starting materials - and differentiation, in which those materials evolve into functioning neurons.

5 Oct 2009

Bipolar Disorder News and Research

Latest Bipolar Disorder News and Research

Memphis Mayor supports new program that assists individuals with bipolar disorder

Memphis Mayor supports National Bipolar Foundation; sees benefit in preventative care program

Malfunctioning circadian clock genes may be associated with bipolar disorder in children

Online patient support program for ADHD patients taking Vyvanse Capsules CII medication

Bipolar disorder drug market to decline from $6.3 billion to $5 billion

Second-quarter fiscal 2010 results announced by Repligen

International Omega-3 Awareness Day to educate public about proven health benefits of omega-3

Shire to present key data on ADHD treatments at national psychiatric meeting

Shire announces Phase IIIb study results of Daytrana

NARSAD to present Productive Lives Award to Randy Lewis

Shire's ADHD treatment data to be presented at the Honolulu psychiatric meeting

NBPF develops 'Safe 'til Stable' preventative care program for bipolar disorder patients

Pediatric and adolescent patients who receive antipsychotic medications experience weight gain

ADA Technologies to develop home lithiummonitor for patients with bipolar disorder

Shire announces new pharmacokinetic data of ADHD medication

SAMHSA honors contributors to mental health recovery at the 2009 Voice Awards

WCMC-Q program highlights the importance of mental health to overall physical health

Three hundred participants sought for world-first study to determine shared biological basis for psychotic illnesses

DoD funds Screening for Mental Health's awareness program for military personnel

Study shows that GSK-3 gene determines the total number of neurons required for brain

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Bipolar Disorder News and Research

Latest Bipolar Disorder News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in